Monsanto Co. (NYSE:MON) EVP Kerry J. Preete sold 2,745 shares of the company’s stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the transaction, the executive vice president now owns 50,056 shares of the company’s stock, valued at $5,053,653.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Monsanto Co. (NYSE:MON) opened at 101.21 on Monday. The stock has a 50 day moving average of $101.13 and a 200-day moving average of $103.57. The company has a market capitalization of $44.33 billion, a PE ratio of 33.87 and a beta of 1.01. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same quarter in the previous year, the firm earned ($0.19) EPS. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. Analysts predict that Monsanto Co. will post $4.73 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

A number of equities analysts recently weighed in on the stock. TheStreet lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, September 12th. Citigroup Inc. upped their target price on shares of Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research report on Friday, August 19th. Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday, October 7th. Monness Crespi & Hardt dropped their target price on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research report on Monday, October 3rd. Finally, JPMorgan Chase & Co. set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research report on Thursday, October 6th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $114.65.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Svenska Handelsbanken AB publ bought a new stake in shares of Monsanto during the third quarter valued at about $1,404,000. WFG Advisors LP raised its stake in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Signaturefd LLC raised its stake in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Finally, Pinkerton Retirement Specialists LLC raised its stake in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Institutional investors and hedge funds own 78.26% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.